Genmab A/S (GMAB) Reports FY EPS of $15.37

Genmab A/S (NASDAQ: GMAB) reported FY EPS of $15.37. Revenue for the period came in at $3.72 billion.

For earnings history and earnings-related data on Genmab A/S (GMAB) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15